3M Reports Fourth-Quarter and Full-Year 2021 Results
Fourth-Quarter Highlights:
- Sales of $8.6 billion, up 0.3 percent year-on-year; organic local-currency sales increased 1.3 percent year-on-year
- Earnings per share of $2.31
- Operating cash flow of $2.0 billion; adjusted free cash flow of $1.5 billion, down 30 percent year-on-year
- Returned $1.8 billion to shareholders via dividends and gross share repurchases
- Announced Food Safety business divestiture involving a Reverse Morris Trust transaction with NEOGEN Corporation
Full Year Highlights:
- Sales of $35.4 billion, up 9.9 percent year-on-year; organic local-currency sales increased 8.8 percent year-on-year
- Earnings per share of $10.12 vs. $9.36 in 2020, up 8 percent year-on-year
- Adjusted earnings per share of $10.12 vs. $8.85 in 2020, up 14 percent year-on-year

ST. PAUL, Minn., Jan. 25, 2022 /PRNewswire/ -- 3M (NYSE: MMM) today reported fourth-quarter and full-year 2021 results.

"3M delivered a solid fourth-quarter performance – with notable strength in December – as we maintained our relentless focus on serving customers in a challenging external environment," said 3M chairman and chief executive officer Mike Roman. "Our team effectively managed supply chain disruptions, made good progress on pricing actions and controlled costs."

"Throughout 2021 we performed well, delivering full-year sales growth of 10 percent, robust cash flow and a strong increase in EPS. We also returned significant cash to shareholders, reduced debt and helped the world respond to COVID-19," Roman continued. "As we continue to actively manage our portfolio and improve our operations, we will prioritize investments in fast-growing end markets to drive long-term growth, as well as advance our commitment to sustainability. As we enter 2022, I am confident we will continue to grow our business and find new ways to apply science to improve lives."

Fourth-Quarter Results

Sales grew 0.3 percent year-on-year to $8.6 billion. Organic local-currency sales increased 1.3 percent. Foreign currency translation decreased sales by 1.0 percent year-on-year.

Total sales grew 4.1 percent in Consumer and 0.7 percent in Health Care, and decreased 1.5 percent in Transportation and Electronics, and 2.2 percent in Safety and Industrial. Organic local-currency sales grew 4.9 percent in Consumer and 1.6 percent in Health Care, and decreased 0.4 percent in Transportation and Electronics, and 1.3 percent in Safety and Industrial.

On a geographic basis, total sales grew 2.1 percent in the Americas, and decreased 0.2 percent in Asia Pacific, and 4.5 percent in EMEA (Europe, Middle East and Africa). Organic local-currency sales grew 2.2 percent in the Americas, 1.4 percent in Asia Pacific, and decreased 1.9 percent in EMEA.

Fourth-quarter earnings per share was $2.31 per share, down 4 percent year-on-year. Fourth quarter operating income was $1.6 billion with operating margins of 18.8 percent.

The company's operating cash flow was $2.0 billion with adjusted free cash flow of $1.5 billion contributing to adjusted free cash flow conversion of 110 percent. 3M returned $1.8 billion to shareholders in the fourth quarter of 2021, including $848 million in cash dividends and $938 million of gross share repurchases. See the "Supplemental Financial Information Non-GAAP Measures" section for applicable information.

Fourth-Quarter Business Group Discussion

Safety and Industrial

  • Sales of $3.1 billion, down 2.2 percent in U.S. dollars. Organic local-currency sales decreased 1.3 percent, and foreign currency translation decreased sales by 0.9 percent.
  • On an organic basis:
    • Sales increased in closure and masking systems, abrasives, industrial adhesives and tapes, electrical markets and automotive aftermarket, and decreased in roofing granules and personal safety.
  • Segment operating income was $543 million, a decrease of 21.7 percent year-on-year; operating margins of 17.7 percent.

Transportation and Electronics

  • Sales of $2.3 billion, down 1.5 percent in U.S. dollars. Organic local-currency sales decreased 0.4 percent, and foreign currency translation decreased sales by 1.1 percent.
  • On an organic basis:
    • Sales increased in commercial solutions and advanced materials, and decreased in electronics, transportation safety and automotive and aerospace.
  • Segment operating income was $406 million, a decrease of 14.7 percent year-on-year; operating margins of 17.6 percent.

Health Care

  • Sales of $2.3 billion, up 0.7 percent in U.S. dollars. Organic sales increased 1.6 percent and, foreign currency translation decreased sales by 0.9 percent.
  • On an organic basis:
    • Sales increased in separation and purification, food safety, health information systems and oral care, and decreased in medical solutions.
  • Segment operating income was $536 million, a decrease of 1.6 percent year-on-year; operating margins were 23.6 percent.

Consumer

  • Sales of $1.5 billion, up 4.1 percent in U.S. dollars. Organic sales increased 4.9 percent, and foreign currency translation decreased sales by 0.8 percent.
  • On an organic basis:
    • Sales increased in consumer health and safety, stationery and office, home improvement and home care.
  • Segment operating income was $316 million, a decrease 0.4 percent year-on-year; operating margins were 21.4 percent.

Full-Year 2021 Results

Full-year 2021 sales increased 9.9 percent year-on-year to $35.4 billion. Organic local-currency sales increased 8.8 percent while acquisitions, net of divestitures, decreased sales by 0.5 percent. Foreign currency translation increased sales by 1.6 percent year-on-year.

Both GAAP and adjusted earnings were $10.12 per share, an increase of 8 percent on a GAAP basis and an increase of 14 percent on an adjusted basis, as referenced in the "Supplemental Financial Information Non-GAAP Measures" section. Full-year operating income was $7.4 billion with operating margins of 20.8 percent.

The company's operating cash flow was $7.5 billion with adjusted free cash flow of $6.0 billion, contributing to adjusted free cash flow conversion of 101 percent for the year. In addition, 3M generated 19.5 percent return on invested capital. Refer to the "Supplemental Financial Information Non-GAAP Measures" section.

For the full year, 3M paid $3.4 billion in cash dividends to shareholders and repurchased $2.2 billion of its own shares.

3M will conduct an investor teleconference at 9 a.m. EST (8 a.m. CST) today. Investors can access this conference via the following:

  • Live webcast at http://investors.3M.com.
  • Live telephone:
    Call 800-762-2596 within the U.S. or +1 212-231-2916 outside the U.S. Please join the call at least 10 minutes before the start time.
  • Webcast replay:
    Go to 3M's Investor Relations website at http://investors.3M.com and click on "Quarterly Earnings."
  • Telephone replay:
    Call 800-633-8284 within the U.S. or +1 402-977-9140 outside the U.S. (for both U.S. and outside the U.S., the access code is 21999288). The telephone replay will be available until 11:30 a.m. EST (10:30 a.m. CST) on Feb. 1, 2022.

Strategic Update and 2022 Outlook Meeting

3M will host a virtual strategic update and 2022 outlook meeting on Monday, Feb. 14, 2022, starting at 9 a.m. EST (8 a.m. CST). The event can be accessed via telephone at (800) 762-2596 within the U.S. or +1 (212) 231-2916 outside the U.S. This event will be webcast live, and a replay will be available on 3M's Investor Relations website at http://investors.3M.com.

Forward-Looking Statements

This news release contains forward-looking information about 3M's financial results and estimates and business prospects that involve substantial risks and uncertainties. You can identify these statements by the use of words such as "anticipate," "estimate," "expect," "aim," "project," "intend," "plan," "believe," "will," "should," "could," "target," "forecast" and other words and terms of similar meaning in connection with any discussion of future operating or financial performance or business plans or prospects. Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, regulatory, capital markets and other external conditions and other factors beyond the Company's control, including natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) risks related to public health crises such as the global pandemic associated with the coronavirus (COVID-19); (3) foreign currency exchange rates and fluctuations in those rates; (4) liabilities related to certain fluorochemicals, including lawsuits concerning various PFAS-related products and chemistries, and claims and governmental regulatory proceedings and inquiries related to PFAS in a variety of jurisdictions; (5) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual Report on Form 10-K for the year ended December 31, 2020, and any subsequent quarterly reports on Form 10-Q (the "Reports"); (6) competitive conditions and customer preferences; (7) the timing and market acceptance of new product offerings; (8) the availability and cost of purchased components, compounds, raw materials, labor, and energy (including oil and natural gas and their derivatives) due to shortages, increased demand and wages, logistics, manufacturing site disruptions or supply chain interruptions (including those caused by natural and other disasters and other events); (9) unanticipated problems or delays with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) the impact of acquisitions, strategic alliances, divestitures and other unusual events resulting from portfolio management actions and other evolving business strategies, and possible organizational restructuring; (11) operational execution, including scenarios where the Company generates fewer productivity improvements than estimated; (12) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; (13) the Company's credit ratings and its cost of capital; and (14) tax-related external conditions, including changes in tax rates, laws or regulations. Changes in such assumptions or factors could produce significantly different results. A further description of these factors is located in the Reports under "Cautionary Note Concerning Factors That May Affect Future Results" and "Risk Factors" in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports), as updated by applicable Current Reports on Form 8-K. The information contained in this news release is as of the date indicated. The Company assumes no obligation to update any forward-looking statements contained in this news release as a result of new information or future events or developments.

 

 

 

3M Company and Subsidiaries

CONSOLIDATED STATEMENT OF INCOME

(Millions, except per-share amounts)

(Unaudited)

 
   

Three months ended December 31,

 

Year ended
December 31,

   

2021

 

2020

 

2021

 

2020

Net sales

 

$       8,612

 

$       8,583

 

$     35,355

 

$     32,184

                 

Operating expenses

               

Cost of sales

 

4,698

 

4,388

 

18,795

 

16,605

Selling, general and administrative expenses

 

1,824

 

1,890

 

7,197

 

6,929

Research, development and related expenses

 

474

 

456

 

1,994

 

1,878

Gain on sale of businesses

 

 

 

 

(389)

Total operating expenses

 

6,996

 

6,734

 

27,986

 

25,023

Operating income

 

1,616

 

1,849

 

7,369

 

7,161

                 

Other expense (income), net

 

52

 

118

 

165

 

366

                 

Income before income taxes

 

1,564

 

1,731

 

7,204

 

6,795

Provision for income taxes

 

227

 

321

 

1,285

 

1,337

Income of consolidated group

 

1,337

 

1,410

 

5,919

 

5,458

                 

Income (loss) from unconsolidated subsidiaries, net of taxes

 

3

 

(4)

 

10

 

(5)

Net income including noncontrolling interest

 

1,340

 

1,406

 

5,929

 

5,453

                 

Less: Net income (loss) attributable to noncontrolling interest

 

1

 

1

 

8

 

4

                 

Net income attributable to 3M

 

$       1,339

 

$       1,405

 

$       5,921

 

$       5,449

                 

Weighted average 3M common shares outstanding – basic

 

574.9

 

578.7

 

579.0

 

577.6

Earnings per share attributable to 3M common shareholders – basic

 

$         2.33

 

$         2.43

 

$       10.23

 

$         9.43

                 

Weighted average 3M common shares outstanding – diluted

 

579.9

 

584.0

 

585.3

 

582.2

Earnings per share attributable to 3M common shareholders – diluted

 

$         2.31

 

$         2.41

 

$       10.12

 

$         9.36

 

 

 

3M Company and Subsidiaries

CONDENSED CONSOLIDATED BALANCE SHEET

(Dollars in millions)

(Unaudited)

 
   

December 31,
2021

 

December 31,
2020

ASSETS

       

Current assets

       

Cash and cash equivalents

 

$              4,564

 

$              4,634

Marketable securities – current

 

201

 

404

Accounts receivable – net

 

4,660

 

4,705

Inventories

 

4,985

 

4,239

Prepaids

 

654

 

675

Other current assets

 

339

 

325

Total current assets

 

15,403

 

14,982

Property, plant and equipment – net

 

9,429

 

9,421

Operating lease right of use assets

 

858

 

864

Goodwill and intangible assets – net

 

18,774

 

19,637

Other assets

 

2,608

 

2,440

Total assets

 

$            47,072

 

$            47,344

LIABILITIES AND EQUITY

       

Current liabilities

       

Short-term borrowings and current portion of long-term debt

 

$              1,307

 

$                  806

Accounts payable

 

2,994

 

2,561

Accrued payroll

 

1,020

 

747

Accrued income taxes

 

260

 

300

Operating lease liabilities – current

 

263

 

256

Other current liabilities

 

3,191

 

3,278

Total current liabilities

 

9,035

 

7,948

Long-term debt

 

16,056

 

17,989

Other liabilities

 

6,864

 

8,476

Total liabilities

 

31,955

 

34,413

Total equity

 

15,117

 

12,931

Shares outstanding

       

December 31, 2021: 571,845,478

       

December 31, 2020: 577,749,638

       

Total liabilities and equity

 

$            47,072

 

$            47,344

 

 

 

3M Company and Subsidiaries

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(Dollars in millions)

(Unaudited)

 
   

Year ended

December 31,

   

2021

 

2020

NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES

 

$              7,454

 

$              8,113

         

Cash flows from investing activities:

       

Purchases of property, plant and equipment

 

(1,603)

 

(1,501)

Acquisitions, net of cash acquired

 

 

(25)

Purchases and proceeds from sale or maturities of marketable securities and investments – net

 

204

 

232

Proceeds from sale of businesses, net of cash sold

 

 

576

Other investing activities

 

82

 

138

         

NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES

 

(1,317)

 

(580)

         

Cash flows from financing activities:

       

Change in debt

 

(1,145)

 

(1,875)

Purchases of treasury stock

 

(2,199)

 

(368)

Proceeds from issuances of treasury stock pursuant to stock option and benefit plans

 

639

 

429

Dividends paid to shareholders

 

(3,420)

 

(3,388)

Other financing activities

 

(20)

 

(98)

         

NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES

 

(6,145)

 

(5,300)

         

Effect of exchange rate changes on cash and cash equivalents

 

(62)

 

48

         

Net increase (decrease) in cash and cash equivalents

 

(70)

 

2,281

Cash and cash equivalents at beginning of year

 

4,634

 

2,353

         

Cash and cash equivalents at end of period

 

$              4,564

 

$              4,634

 

3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES

(Unaudited)

 

(Dollars in millions, except per share amounts)

 

Operating

Income

 

Operating

Income

Margin

 

Income

Before

Taxes

 

Provision

for

Income

Taxes

 

Effective

Tax

Rate

 

Net Income

Attributable

to 3M

 

Earnings

Per

Diluted

Share

 

Earnings

per

diluted

share

percent

change

Q4 2020 GAAP

 

$ 1,849

 

21.5 %

 

$ 1,731

 

$ 321

 

18.6 %

 

$ 1,405

 

$ 2.41

   

Adjustments for special items:

                               

None

                               

Q4 2020 adjusted amounts (non-GAAP measures) (a)

 

$ 1,849

 

21.5 %

 

$ 1,731

 

$ 321

 

18.6 %

 

$ 1,405

 

$ 2.41

   
                                 

Q4 2021 GAAP

 

$ 1,616

 

18.8 %

 

$ 1,564

 

$ 227

 

14.5 %

 

$ 1,339

 

$ 2.31

 

(4) %

Adjustments for special items:

                               

None

                               

Q4 2021 adjusted amounts (non-GAAP measures) (a)

 

$ 1,616

 

18.8 %

 

$ 1,564

 

$ 227

 

14.5 %

 

$ 1,339

 

$ 2.31

 

(4) %

 

(Dollars in millions, except per share amounts)

 

Operating

Income

 

Operating

Income

Margin

 

Income

Before

Taxes

 

Provision

for

Income

Taxes

 

Effective

Tax

Rate

 

Net Income

Attributable

to 3M

 

Earnings

Per

Diluted

Share

 

Earnings

per

diluted

share

percent

change

Full Year 2020 GAAP

 

$ 7,161

 

22.3 %

 

$ 6,795

 

$ 1,337

 

19.7 %

 

$ 5,449

 

$ 9.36

   

Adjustments for special items:

                               

Significant litigation-related charges/benefits

 

17

     

17

 

56

     

(39)

 

(0.07)

   

Gain/loss on sale of businesses

 

(389)

     

(389)

 

(86)

     

(303)

 

(0.52)

   

Divestiture-related restructuring actions

 

55

     

55

 

9

     

46

 

0.08

   

Full Year 2020 adjusted amounts (non-GAAP measure) (a)

 

$ 6,844

 

21.3 %

 

$ 6,478

 

$ 1,316

 

20.3 %

 

$ 5,153

 

$ 8.85

   
                                 

Full Year 2021 GAAP

 

$ 7,369

 

20.8 %

 

$ 7,204

 

$ 1,285

 

17.8 %

 

$ 5,921

 

$ 10.12

 

8 %

Adjustments for special items:

                               

None

                               

Full Year 2021 adjusted amounts (non-GAAP measure) (a)

 

$ 7,369

 

20.8 %

 

$ 7,204

 

$ 1,285

 

17.8 %

 

$ 5,921

 

$ 10.12

 

14 %

 

__________________________

(a)

In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides non-GAAP measures that adjust for the impact of special items. Special items for the periods presented include the items described in the section entitled "Description of Special Items". Operating income (measure of segment operating performance), income before taxes, net income, earnings per share, and effective tax rate are all measures for which 3M provides the reported GAAP measure and a measure adjusted for special items. The adjusted measures are not in accordance with, nor are they a substitute for, GAAP measures. The Company considers these non-GAAP measures in evaluating and managing the Company's operations. The Company believes that discussion of results adjusted for these items is meaningful to investors as it provides a useful analysis of ongoing underlying operating trends. The determination of these items may not be comparable to similarly titled measures used by other companies.

 

3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)

 
   

Three months ended
December 31,

 

Year ended
December 31,

Major GAAP Cash Flow Categories (dollars in millions)

 

2021

 

2020

 

2021

 

2020

Net cash provided by (used in) operating activities

 

$ 2,005

 

$ 2,515

 

$ 7,454

 

$ 8,113

Net cash provided by (used in) investing activities

 

115

 

(259)

 

(1,317)

 

(580)

Net cash provided by (used in) financing activities

 

(2,412)

 

(1,802)

 

(6,145)

 

(5,300)

                 
   

Three months ended
December 31,

 

Year ended
December 31,

Adjusted Free Cash Flow (non-GAAP measure) (dollars in millions)

 

2021

 

2020

 

2021

 

2020

Net cash provided by (used in) operating activities

 

$ 2,005

 

$ 2,515

 

$ 7,454

 

$ 8,113

Purchases of property, plant and equipment

 

(556)

 

(422)

 

(1,603)

 

(1,501)

Free cash flow (b)

 

1,449

 

2,093

 

5,851

 

6,612

Adjustments for special items:

               

Significant litigation-related after-tax payment impacts

 

29

 

5

 

39

 

79

TCJA transition tax payment

 

 

 

77

 

33

Divestiture-related restructuring after-tax payment impacts

 

1

 

6

 

6

 

12

Adjusted free cash flow (c)

 

$ 1,479

 

$ 2,104

 

$ 5,973

 

$ 6,736

                 

Net income attributable to 3M

 

$ 1,339

 

$ 1,405

 

$ 5,921

 

$ 5,449

Adjustments for special items:

               

Significant litigation-related charges/benefits

 

 

 

 

(39)

(Gain)/loss on sale of businesses

 

 

 

 

(303)

Divestiture-related restructuring actions

 

 

 

 

46

Adjusted net income attributable to 3M (a)

 

$ 1,339

 

$ 1,405

 

$ 5,921

 

$ 5,153

Adjusted free cash flow conversion (c)

 

110 %

 

150 %

 

101 %

 

131 %

 

______________________________________

(b)

Free cash flow is not defined under U.S. generally accepted accounting principles (GAAP). Therefore, it should not be considered a substitute for income or cash flow data prepared in accordance with U.S. GAAP and may not be comparable to similarly titled measures used by other companies. The Company defines free cash flow as net cash provided by operating activities less purchases of property, plant and equipment. It should not be inferred that the entire free cash flow amount is available for discretionary expenditures. The Company believes free cash flow is meaningful to investors as it functions as a useful measure of performance and the Company uses this measure as an indication of the strength of the company and its ability to generate cash.

   

(c) 

Adjusted free cash flow and adjusted free cash flow conversion are not defined under U.S. GAAP. Therefore, they should not be considered a substitute for income or cash flow data prepared in accordance with U.S. GAAP and may not be comparable to similarly titled measures used by other companies. The Company defines adjusted free cash flow as net cash provided by operating activities, adjusted for special items, less purchases of property, plant and equipment. Cash payments associated with special items in the determination of adjusted free cash flow are reflected net of applicable tax using the U.S. statutory corporate tax rate during the period of payment. It should not be inferred that the entire adjusted free cash flow amount is available for discretionary expenditures. The Company defines adjusted free cash flow conversion as adjusted free cash flow divided by net income attributable to 3M, adjusted for special items. Special items for the periods presented include the items described in section entitled "Description of Special Items". The Company believes adjusted free cash flow and adjusted free cash flow conversion are meaningful to investors as they are useful measures of performance and the Company uses these measures as an indication of the strength of the company and its ability to generate cash.

 

3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)

(Unaudited)

 
   

Full Year

 

Full Year

Return on Invested Capital (non-GAAP measure) (in millions)

 

2021

 

2020

Net income including non-controlling interest

 

$ 5,929

 

$ 5,453

Interest expense (after-tax) (1)

 

400

 

424

Adjusted net income (Return)

 

$ 6,329

 

$ 5,877

         

Average shareholders' equity (including non-controlling interest) (2)

 

$ 14,497

 

$ 11,507

Average short-term and long-term debt (3)

 

17,991

 

20,413

Average invested capital

 

$ 32,488

 

$ 31,920

         

Return on invested capital (non-GAAP measure) (d)

 

19.5 %

 

18.4 %

         

(1) Effective income tax rate used for interest expense

 

17.8 %

 

19.7 %

         

(2) Calculation of average equity (includes non-controlling interest)

       

Ending total equity as of:

       

March 31

 

$ 13,828

 

$ 10,214

June 30

 

14,516

 

10,925

September 30

 

14,530

 

11,959

December 31

 

15,117

 

12,931

Average total equity

 

$ 14,497

 

$ 11,507

         

(3) Calculation of average debt

       

Ending short-term and long-term debt as of:

       

March 31

 

$ 18,187

 

$ 22,495

June 30

 

18,248

 

20,762

September 30

 

18,165

 

19,598

December 31

 

17,363

 

18,795

Average short-term and long-term debt

 

$ 17,991

 

$ 20,413

   

(d) 

Return on Invested Capital (ROIC) is not defined under U.S. generally accepted accounting principles. Therefore, ROIC should not be considered a substitute for other measures prepared in accordance with U.S. GAAP and may not be comparable to similarly titled measures used by other companies. The Company defines ROIC as adjusted net income (net income including non-controlling interest plus after-tax interest expense) divided by average invested capital (equity plus debt). The Company believes ROIC is meaningful to investors as it focuses on shareholder value creation.

 

3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)

(Unaudited)

 
   

Adjusted EBITDA (non-GAAP
measure) (e)

 

Adjusted EBITDA Margin (non-
GAAP measure) (e)

   

Three months ended December 31,

 

Three months ended December 31,

(Dollars in millions)

 

2021

 

2020

 

2021

 

2020

Safety and Industrial

 

$ 696

 

$ 838

 

22.7 %

 

26.7 %

Transportation and Electronics

 

517

 

589

 

22.4 %

 

25.2 %

Health Care

 

695

 

702

 

30.5 %

 

31.1 %

Consumer

 

355

 

353

 

24.1 %

 

24.9 %

Corporate and Unallocated

 

(15)

 

12

       

Elimination of Dual Credit

 

(125)

 

(147)

       

Total Company

 

$ 2,123

 

$ 2,347

 

24.7 %

 

27.3 %

 
   

Adjusted EBITDA (non-GAAP
measure) (e)

 

Adjusted EBITDA Margin (non-
GAAP measure) (e)

   

Year ended December 31,

 

Year ended December 31,

(Dollars in millions)

 

2021

 

2020

 

2021

 

2020

Safety and Industrial

 

$ 3,285

 

$ 3,346

 

25.5 %

 

28.5 %

Transportation and Electronics

 

2,427

 

2,243

 

24.8 %

 

25.4 %

Health Care

 

2,786

 

2,416

 

30.8 %

 

29.0 %

Consumer

 

1,395

 

1,343

 

23.8 %

 

25.3 %

Corporate and Unallocated

 

(56)

 

(72)

       

Elimination of Dual Credit

 

(553)

 

(521)

       

Total Company

 

$ 9,284

 

$ 8,755

 

26.3 %

 

27.2 %

 
   

Three months ended

 

Year Ended

Adjusted EBITDA (non-GAAP measure) (dollars in millions)

 

December 31, 2021

 

December 31, 2020

 

December 31, 2021

 

December 31, 2020

Net sales

 

$ 8,612

 

$ 8,583

 

$ 35,355

 

$ 32,184

                 

Net income attributable to 3M

 

1,339

 

1,405

 

5,921

 

5,449

Add/(subtract):

               

Net income/(loss) attributable to noncontrolling interest

 

1

 

1

 

8

 

4

(Income)/loss from unconsolidated subsidiaries, net of taxes

 

(3)

 

4

 

(10)

 

5

Provision for income taxes

 

227

 

321

 

1,285

 

1,337

Other expense/(income):

               

Interest (Income)/expense

 

110

 

136

 

462

 

500

Pension & OPEB non-service cost (benefit)

 

(58)

 

(18)

 

(297)

 

(134)

Depreciation and amortization expense

 

507

 

498

 

1,915

 

1,911

Adjustments for special items:

               

Significant litigation-related charges/(benefits)

 

 

 

 

17

(Gain)/loss on sale of businesses

 

 

 

 

(389)

Divestiture-related restructuring actions

 

 

 

 

55

Adjusted EBITDA (e)

 

$ 2,123

 

$ 2,347

 

$ 9,284

 

$ 8,755

                 

Adjusted EBITDA margin (e)

 

24.7 %

 

27.3 %

 

26.3 %

 

27.2 %

 

 

3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)

 

Adjusted EBITDA (non-GAAP measure)
Three months ended December 31, 2021

(dollars in millions)

 

Safety and

Industrial

 

Transportation

and

Electronics

 

Health Care

 

Consumer

 

Corporate

and

Unallocated

 

Elimination

of Dual

Credit

 

Total

Company

Net sales

 

$ 3,064

 

$ 2,306

 

$ 2,275

 

$ 1,476

 

$ —

 

$ (509)

 

$ 8,612

                             

Business segment operating income
(measure of segment operating
performance)

 

543

 

406

 

536

 

316

 

(60)

 

(125)

 

1,616

Add/(subtract):

                           

Depreciation and amortization

 

153

 

111

 

159

 

39

 

45

     

507

Adjustments for special items:

                           

None

                           

Adjusted EBITDA (non-GAAP measure) (e)

 

$ 696

 

$ 517

 

$ 695

 

$ 355

 

$ (15)

 

$ (125)

 

$ 2,123

                             

Adjusted EBITDA margin (non-GAAP measure) (e)

 

22.7 %

 

22.4 %

 

30.5 %

 

24.1 %

         

24.7 %

 

Adjusted EBITDA (non-GAAP measure)
Three months ended December 31, 2020
(dollars in millions)

 

Safety and

Industrial

 

Transportation

and

Electronics

 

Health Care

 

Consumer

 

Corporate

and

Unallocated

 

Elimination

of Dual

Credit

 

Total

Company

Net sales

 

$ 3,133

 

$ 2,341

 

$ 2,258

 

$ 1,418

 

$ (1)

 

$ (566)

 

$ 8,583

                             

Business segment operating income
(measure of segment operating
performance)

 

693

 

476

 

544

 

317

 

(34)

 

(147)

 

1,849

Add/(subtract):

                           

Depreciation and amortization

 

145

 

113

 

158

 

36

 

46

     

498

Adjustments for special items:

                           

None

                           

Adjusted EBITDA (non-GAAP measure) (e)

 

$ 838

 

$ 589

 

$ 702

 

$ 353

 

$ 12

 

$ (147)

 

$ 2,347

                             

Adjusted EBITDA margin (non-GAAP measure) (e)

 

26.7 %

 

25.2 %

 

31.1 %

 

24.9 %

         

27.3 %

 

Adjusted EBITDA (non-GAAP measure)

Year ended December 31, 2021
(dollars in millions)

 

Safety and

Industrial

 

Transportation

and

Electronics

 

Health Care

 

Consumer

 

Corporate

and

Unallocated

 

Elimination

of Dual

Credit

 

Total

Company

Net sales

 

$ 12,880

 

$ 9,769

 

$ 9,050

 

$ 5,856

 

$ 2

 

$ (2,202)

 

$ 35,355

                             

Business segment operating income
(measure of segment operating
performance)

 

2,692

 

2,008

 

2,150

 

1,248

 

(176)

 

(553)

 

7,369

Add/(subtract):

                           

Depreciation and amortization

 

593

 

419

 

636

 

147

 

120

     

1,915

Adjustments for special items:

                           

None

                           

Adjusted EBITDA (non-GAAP measure) (e)

 

$ 3,285

 

$ 2,427

 

$ 2,786

 

$ 1,395

 

$ (56)

 

$ (553)

 

$ 9,284

                             

Adjusted EBITDA margin (non-GAAP measure) (e)

 

25.5 %

 

24.8 %

 

30.8 %

 

23.8 %

         

26.3 %

 

Adjusted EBITDA (non-GAAP measure)

Year ended December 31, 2020
(dollars in millions)

 

Safety and

Industrial

 

Transportation

and

Electronics

 

Health Care

 

Consumer

 

Corporate

and

Unallocated

 

Elimination

of Dual

Credit

 

Total

Company

Net sales

 

$ 11,734

 

$ 8,833

 

$ 8,345

 

$ 5,311

 

$ (2)

 

$ (2,037)

 

$ 32,184

                             

Business segment operating income
(measure of segment operating
performance)

 

2,784

 

1,814

 

1,790

 

1,203

 

91

 

(521)

 

7,161

Add/(subtract):

                           

Depreciation and amortization

 

562

 

429

 

626

 

140

 

154

     

1,911

Adjustments for special items:

                           

Significant litigation-related charges/benefits

                 

17

     

17

(Gain)/loss on sale of businesses

                 

(389)

     

(389)

Divestiture-related restructuring actions

                 

55

     

55

Adjusted EBITDA (non-GAAP measure) (e)

 

$ 3,346

 

$ 2,243

 

$ 2,416

 

$ 1,343

 

$ (72)

 

$ (521)

 

$ 8,755

                             

Adjusted EBITDA margin (non-GAAP measure) (e)

 

28.5 %

 

25.4 %

 

29.0 %

 

25.3 %

         

27.2 %

 

 

______________________________________

(e) 

Adjusted EBITDA and adjusted EBITDA margin are not defined under U.S. GAAP. Therefore, adjusted EBITDA and adjusted EBITDA margin should not be considered a substitute for other measures prepared in accordance with U.S. GAAP and may not be comparable to similarly titled measures used by other companies. The Company defines adjusted EBITDA as net income attributable to 3M, adjusted for net income/(loss) attributable to noncontrolling interest, (income)/loss from unconsolidated subsidiaries, provision for income taxes, other expense/(income), depreciation and amortization expense, and special items. For business segments, the Company defines adjusted EBITDA as business segment operating income (3M's measure of segment operating performance) adjusted for depreciation and amortization expense. The Company defines adjusted EBITDA margin as adjusted EBITDA divided by net sales. Special items for the periods presented include the items described in the section entitled "Description of Special Items". The Company considers these non-GAAP measures in evaluating and managing the Company's operations. The Company believes adjusted EBITDA and adjusted EBITDA margin are meaningful to investors as they provide useful analyses of ongoing underlying operating trends.

   

Net Debt (non-GAAP measure)

 

December 31,
2021

 

December 31,
2020

Total debt

 

$ 17,363

 

$ 18,795

Less: Cash, cash equivalents and marketable securities

 

4,792

 

5,068

Net debt (f)

 

$ 12,571

 

$ 13,727

 

______________________________________

(f) 

Net debt is not defined under U.S. GAAP and may not be computed the same as similarly titled measures used by other companies. The Company defines net debt as total debt less the total of cash, cash equivalents and current and long-term marketable securities. 3M believes net debt is meaningful to investors as 3M considers net debt and its components to be an important indicator of liquidity and a guiding measure of capital structure strategy.

 

3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)

(Unaudited)

Description of Special Items:

In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides various non-GAAP measures that incorporate adjustments for the impacts of special items. Special items incorporated in the preparation of these non-GAAP measures for the periods presented include the items described below:

Significant litigation-related charges/benefits:

  • In the first quarter of 2020, 3M recorded a net pre-tax charge of $17 million ($13 million after tax) related to PFAS (certain perfluorinated compounds) matters. The charge was more than offset by a reduction in tax expense of $52 million related to resolution of tax treatment with authorities regarding the previously disclosed 2018 agreement reached with the State of Minnesota that resolved the Natural Resources Damages lawsuit. These items, in aggregate, resulted in a $39 million after-tax benefit. In the fourth quarter of 2021 and 2020, 3M made payments of approximately $35 million and $6 million, respectively, related to significant litigation-related matters. In the full year of 2021 and 2020, 3M made payments of approximately $49 million and $100 million, respectively, related to significant litigation-related matters.

Gain/loss on sale of businesses:

  • In the first quarter of 2020, 3M recorded a pre-tax gain of $2 million ($1 million loss after tax) related to the sale of its advanced ballistic-protection business and recognition of certain contingent consideration. In the second quarter of 2020, 3M recorded a pre-tax gain of $387 million ($304 million after tax) related to the sale of its drug delivery business.

Divestiture-related restructuring actions:

  • In the fourth quarter and full year of 2021, 3M made payments of approximately $1 million and $8 million, respectively, associated with divestiture-related restructuring actions.
  • In the second quarter of 2020, following the divestiture of substantially all of the drug delivery business, management approved and committed to undertake certain restructuring actions addressing corporate functional costs and manufacturing footprint across 3M in relation to the magnitude of amounts previously allocated/burdened to the divested business. As a result, 3M recorded a pre-tax charge of $55 million ($46 million after tax). In the fourth quarter and full year of 2020, 3M made payments of approximately $7 million and $14 million, respectively, associated with these restructuring actions.

Enactment/measurement period adjustments related to the Tax Cuts and Jobs Act (TCJA)

  • In the full year of 2021 and 2020, 3M made payments of approximately $77 million and $33 million, respectively, related to the transition tax expense incurred as a result of the 2017 enactment of the TCJA.

 

 

 

3M Company and Subsidiaries

SALES CHANGE ANALYSIS (g)

(Unaudited)

 
   

Three months ended December 31, 2021

Sales Change Analysis by Geographic Area

 

Americas

 

Asia-

Pacific

 

Europe,

Middle

East and

Africa

 

World-

Wide

Volume – organic

             

(1.3) %

Price

             

2.6

Organic local-currency sales

 

2.2

 

1.4

 

(1.9)

 

1.3

Divestitures

 

 

 

 

Translation

 

(0.1)

 

(1.6)

 

(2.6)

 

(1.0)

Total sales change

 

2.1 %

 

(0.2) %

 

(4.5) %

 

0.3 %

 
     
   

Three months ended December 31, 2021

Worldwide Sales Change by Business Segment

 

Organic local-
currency sales

 

Acquisitions

 

Divestitures

 

Translation

 

Total sales

change

Safety and Industrial

 

(1.3) %

 

— %

 

— %

 

(0.9) %

 

(2.2) %

Transportation and Electronics

 

(0.4)

 

 

 

(1.1)

 

(1.5)

Health Care

 

1.6

 

 

 

(0.9)

 

0.7

Consumer

 

4.9

 

 

 

(0.8)

 

4.1

Total Company

 

1.3

 

 

 

(1.0)

 

0.3

 
 
   

Year ended December 31, 2021

Sales Change Analysis by Geographic Area

 

Americas

 

Asia-

Pacific

 

Europe,

Middle

East and

Africa

 

World-

Wide

Volume – organic

             

7.5 %

Price

             

1.3

Organic local-currency sales

 

9.8

 

8.5

 

6.3

 

8.8

Divestitures

 

(0.6)

 

 

(1.1)

 

(0.5)

Translation

 

0.3

 

2.3

 

3.8

 

1.6

Total sales change

 

9.5 %

 

10.8 %

 

9.0 %

 

9.9 %

 
 
   

Year ended December 31, 2021

Worldwide Sales Change by Business Segment

 

Organic local-
currency sales

 

Acquisitions

 

Divestitures

 

Translation

 

Total sales

change

Safety and Industrial

 

7.8 %

 

— %

 

— %

 

2.0 %

 

9.8 %

Transportation and Electronics

 

9.0

 

 

 

1.6

 

10.6

Health Care

 

8.6

 

 

(1.9)

 

1.7

 

8.4

Consumer

 

9.3

 

 

 

1.0

 

10.3

Total Company

 

8.8

 

 

(0.5)

 

1.6

 

9.9

 

______________________________________

(g)

Total sales change is calculated based on reported sales results. The components of sales change include organic sales, acquisitions, divestitures, and translation. Organic sales include both organic volume impacts (which excludes acquisition and divestiture impacts) and selling price changes. Acquisition and divestiture impacts are measured separately for the first 12 months post-transaction.

 

 

 

3M Company and Subsidiaries
BUSINESS SEGMENTS
(Unaudited)

3M discloses business segment operating income as its measure of segment profit/loss, reconciled to both total 3M operating income and income before taxes. Note 19 to 3M's consolidated financial statements in its 2020 Annual Report on Form 10-K describes 3M's business segments and measure of segment operating performance used by 3M's chief operating decision maker (CODM). As discussed therein, the measure of segment operating performance includes dual credit for certain related operating income and excludes certain expenses and income that are not allocated to business segments and instead reflected in Corporate and Unallocated. Additionally, the following special items are excluded from business segment operating income and, instead, are included within Corporate and Unallocated: significant litigation-related charges/benefits, gain/loss on sale of businesses, and divestiture-related restructuring actions.

Effective in the first quarter of 2021, the measure of segment operating performance used by 3M's CODM changed and, as a result, 3M's disclosed measure of segment profit/loss (business segment operating income) was updated. The change to business segment operating income aligns with the update to how the CODM assesses performance and allocates resources for the Company's business segments. The change included the following:

Changes in cost attribution

The extent of allocation and method of attribution of certain net costs were updated to result in fewer items remaining in Corporate and Unallocated and, instead, including them in 3M's business segments' operating performance. Previously, a larger portion of ongoing corporate staff costs and costs associated with centrally managed material resource centers was retained in Corporate and Unallocated. In addition, portions of pension costs and costs associated with certain centrally managed but ongoing business-related legal matters, along with certain insurance-related costs, were retained in Corporate and Unallocated.

Continued alignment of customer account activity

As part of 3M's regular customer-focus initiatives, the Company realigned certain customer account activity ("sales district") to correlate with the primary divisional product offerings in various countries and reduce complexity for customers when interacting with multiple 3M businesses. This impacted the amount of dual credit certain business segments receive as a result of sales district attribution.

Also effective in the first quarter of 2021, within 3M's Consumer business segment, certain safety products formerly within the Construction and Home Improvement Division and the Stationery and Office Division were moved to the newly named Consumer Health and Safety Division (formerly the Consumer Health Care Division).

The financial information presented herein reflects the impact of the preceding changes for all periods presented.

BUSINESS SEGMENT INFORMATION

 

Three months ended December 31,

 

Year ended December 31,

NET SALES

   

(Millions)

 

2021

 

2020

 

2021

 

2020

Safety and Industrial

 

$ 3,064

 

$ 3,133

 

$ 12,880

 

$ 11,734

Transportation and Electronics

 

2,306

 

2,341

 

9,769

 

8,833

Health Care

 

2,275

 

2,258

 

9,050

 

8,345

Consumer

 

1,476

 

1,418

 

5,856

 

5,311

Corporate and Unallocated

 

 

(1)

 

2

 

(2)

Elimination of Dual Credit

 

(509)

 

(566)

 

(2,202)

 

(2,037)

Total Company

 

$ 8,612

 

$ 8,583

 

$ 35,355

 

$ 32,184

 
 

BUSINESS SEGMENT INFORMATION

 

Three months ended December 31,

 

Year ended December 31,

OPERATING INCOME

   

(Millions)

 

2021

 

2020

 

2021

 

2020

Safety and Industrial

 

$ 543

 

$ 693

 

$ 2,692

 

$ 2,784

Transportation and Electronics

 

406

 

476

 

2,008

 

1,814

Health Care

 

536

 

544

 

2,150

 

1,790

Consumer

 

316

 

317

 

1,248

 

1,203

Elimination of Dual Credit

 

(125)

 

(147)

 

(553)

 

(521)

Total business segment operating income

 

1,676

 

1,883

 

7,545

 

7,070

Corporate and Unallocated

               

Special items:

               

Significant litigation-related (charges)/benefits

 

 

 

 

(17)

Gain/(loss) on sale of businesses

 

 

 

 

389

Divestiture-related restructuring actions

 

 

 

 

(55)

Other corporate expense - net

 

(60)

 

(34)

 

(176)

 

(226)

Total Corporate and Unallocated

 

(60)

 

(34)

 

(176)

 

91

Total Company operating income

 

1,616

 

1,849

 

7,369

 

7,161

                 

Other expense/(income), net

 

52

 

118

 

165

 

366

Income before income taxes

 

$ 1,564

 

$ 1,731

 

$ 7,204

 

$ 6,795

 

About 3M

At 3M, we apply science in collaborative ways to improve lives daily as our employees connect with customers all around the world. Learn more about 3M's creative solutions to the world's problems at www.3M.com or on Twitter @3M or @3MNews.

Please note that the company announces material financial, business and operational information using the 3M investor relations website, SEC filings, press releases, public conference calls and webcasts. The company also uses the 3M news center and social media to communicate with our customers and the public about the company, products and services and other matters. It is possible that the information 3M posts on the news center and social media could be deemed to be material information. Therefore, the company encourages investors, the media and others interested in 3M to review the information posted on 3M's news center and the social media channels such as Twitter@3M or @3MNews.

Contacts
3M
Investor Contacts:
Bruce Jermeland, 651-733-1807
or
Diane Farrow, 612-202-2449
or
Media Contact:
Tim Post, tpost@mmm.com


 

SOURCE 3M

Other Topics

Contact Media Relations

Contact Media Email
 

These contacts are intended only for the media. If you are not a member of the media, please call 1-888-3M HELPS (1-888-364-3577).
 

We will get back to you within one business day.

Email Alerts

Subscribe to receive automatic updates via email for 3M news & stories.

Subscribe